Navigation Links
Genetic Discovery May Improve Hepatitis C Treatment
Date:8/17/2009

Finding will help predict patient response to therapy, researchers say

MONDAY, Aug. 17 (HealthDay News) -- The first biomarker that predicts a patient's response to hepatitis C treatments has been identified by U.S. researchers.

The new marker is a single letter change -- a C instead of a T -- in a segment of DNA near the IL28B gene, according to the Duke University Medical Center team. They found it by studying the DNA of 1,671 people taking part in a study of hepatitis C treatments.

Not only does this biomarker predict who is most likely to respond to treatment and who isn't, it may solve the long-standing question of why responses to hepatitis C treatments vary so widely among racial and ethnic groups.

"For geneticists, understanding response to treatment for hepatitis C infection has been almost like a Holy Grail," study senior author David Goldstein, director of the Center for Human Genome Variation at Duke's Institute for Genome Sciences & Policy, said in a university news release.

"The side effects of hepatitis treatment can be brutal, and about half the time, the treatment fails to eradicate the virus. This discovery enables us to give patients valuable information that will help them and their doctors decide what is best for them. This is what personalized medicine is all about," Goldstein said.

The study appeared online Aug. 16 in the journal Nature.

Hepatitis C, one of the most common infections in the world, affects about 170 million people. Treatment typically involves 48 weeks of interferon plus the antiviral drug ribavirin. Black patients are less likely to respond to treatment than white patients, while East Asian patients seem to have the best response.

More information

The U.S. Centers for Disease Control and Prevention has more about hepatitis C.



-- Robert Preidt



SOURCE: Duke University Medical Center, news release, Aug. 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Genetic Link Suspected for Muscular Dystrophy
2. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
3. Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc.
4. March of Dimes Celebrates 50th Anniversary of Genetics Short Course
5. Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease
6. Genetic testing may be valuable in treating colorectal cancer
7. NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism: Fragile X
8. Studies Show Genetic Activity of Antioxidants
9. Genetic Variation Associated With Survival Advantage in African Americans With HIV
10. Study Shows a Link Between Schizophrenia & Genetic Mutations
11. Teen Behaviors Stem From Genetics, Environment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Discovery May Improve Hepatitis C Treatment
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology: